Please wait a minute...
European Journal of Gynaecological Oncology  2021, Vol. 42 Issue (1): 165-167    DOI: 10.31083/j.ejgo.2021.01.2166
Case Report Previous articles | Next articles
Cutaneous leukocytoclastic vasculitis in a patient treated with carboplatin for uterine carcinoma
Mirjana Rajer1, 2, Brigita Gregoric1, Milanka Zivanovic3, Erik Skof 1, 2, *()
1Department of Medical Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia
2Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia
3Institute of Pathology, Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia
Download:  PDF(8580KB)  ( 55 ) Full text   ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Cutaneous leukocytoclastic vasculitis (LCV) is a histopathological term used to refer to inflammation of the small vessels, including arterioles, capillaries and postcapillary venules, in the skin. The main morphological features of LCV are fibrinoid necrosis of the vessel wall with mainly neutrophilic infiltration and leukocytoclasis. LCV can be idiopathic or triggered by several causes, such as medications, underlying infection and malignancies. IgA vasculitis is a type of LCV with IgA-dominant immune deposits in the vascular wall. We report a rare case of skin-limited IgA vasculitis after treatment with carboplatin in a patient with uterine cancer. To our knowledge, this is the first reported case of LCV (in our case, skin-limited IgA vasculitis) connected to carboplatin treatment. A 57-year-old patient with uterine carcinoma was treated with surgery. Afterwards, she received postoperative chemotherapy with pegylated liposomal doxorubicin (PLD) in combination with carboplatin. When the disease progressed, the patient received carboplatin monotherapy; after the third round of carboplatin therapy, she developed IgA vasculitis of the skin without systemic involvement. Chemotherapy with carboplatin was discontinued. She was treated symptomatically, and after six months, the skin lesions resolved and had not reappeared as of her last visit. Carboplatin can induce LCV, and clinicians should be aware of this potential effect for the proper management of affected patients.
Key words:  Vasculitis      Leukocytoclastic      Cutaneous      Carboplatin     
Submitted:  09 June 2020      Revised:  12 August 2020      Accepted:  19 August 2020      Published:  15 February 2021     
*Corresponding Author(s):  Erik Skof     E-mail:  eskof@onko-i.si

Cite this article: 

Mirjana Rajer, Brigita Gregoric, Milanka Zivanovic, Erik Skof. Cutaneous leukocytoclastic vasculitis in a patient treated with carboplatin for uterine carcinoma. European Journal of Gynaecological Oncology, 2021, 42(1): 165-167.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2021.01.2166     OR     https://ejgo.imrpress.com/EN/Y2021/V42/I1/165

[1] X. Zhang, Y. Fu, X. Zhang, J. Ding, K. Hua. The effect of transcutaneous electrical stimulation treatment in combination with intraoperative nerve staining on sexual function after radical hysterectomy: a pilot study[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 188-191.
[2] M. Cantos, A. Agrawal, R. Chibbar, C. Theoret. An unusual finding of vulvar Ewing sarcoma - a case report and review of literature[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 849-855.
[3] J.J. Noh, H. Jung, C.H. Choi. Mesonephric adenocarcinoma treated with paclitaxel-carboplatin adjuvant chemotherapy: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 679-683.
[4] G.-L. Zhang, C.-X. Ba, A.-Y. Liu, D.-Q. Ren, H. Li, J.-J. Zhu, J.-N. Fan, P.-L. Zhang. Investigation of paclitaxel-carboplatin one-cycle neoadjuvant chemotherapy plus trastuzumab in HER2-positive breast cancer[J]. European Journal of Gynaecological Oncology, 2018, 39(6): 899-902.
[5] J. Coronel, D. Cantú, M. RodrÍguez-Morales, L. Cetina, A. González-Fierro, A. Dueñas-González. Carboplatin and low-dose paclitaxel. An effective regimen in older and comorbid patients with advanced cervical cancer. A phase II study[J]. European Journal of Gynaecological Oncology, 2018, 39(6): 997-1001.
[6] S. Pantovic, A. Stefanovic, J. Dotlic, S. Kadija, K. Jeremic, I. Likic, S. Repac, J. Stojnic, Z. Vilendecic, I. Pilic. Ovarian carcinoma diagnostic challenge: large ovarian carcinoma giving umbilical subcutaneous metastases without infiltrating intestines[J]. European Journal of Gynaecological Oncology, 2018, 39(5): 813-816.
[7] K. Chikazawa, S. Netsu, R. Konno, S. Motomatsu. Concurrent external beam pelvic radiotherapy and weekly paclitaxel/carboplatin therapy followed by hysterectomy improves prognosis and survival of patients with non-squamous cell carcinoma of the cervix[J]. European Journal of Gynaecological Oncology, 2017, 38(6): 860-866.
[8] W. Kudaka, T. Nakasone, Y. Arakaki, T. Nakamoto, A. Wakayama, Y. Kinjyo, Y. Taira, Y. Nagai, I. Kaneshima, K. Nishihira, Y. Aoki. Adjuvant docetaxel and carboplatin chemotherapy for patients with high-intermediate and high-risk endometrial cancer[J]. European Journal of Gynaecological Oncology, 2017, 38(6): 917-920.
[9] Chao Yang, Juan Tan, Chang-chun Li, Jun Zhang, Xiang-ru Kong, Zhenzhen Zhao, Xiao-bin Deng, Liang Peng, Shan Wang. Fatal overdosage with cisplatin by accidental substitution for carboplatin: a case report and literature review[J]. European Journal of Gynaecological Oncology, 2017, 38(6): 981-984.
[10] D. Nakayama, H. Nishi, R. Kato, Y. Sagawa, F. Terauchi, K. Isaka. Biweekly administration of docetaxel and carboplatin for advanced or recurrent endometrial and ovarian carcinomas[J]. European Journal of Gynaecological Oncology, 2016, 37(4): 488-492.
[11] K. Chikazawa, S. Netsu, R. Konno. Outcomes of concurrent radiotherapy and weekly paclitaxel/carboplatin therapy in cervical cancer: a retrospective study[J]. European Journal of Gynaecological Oncology, 2016, 37(4): 511-516.
[12] J. Wade, S. Armon, O.M. McNally. Ovarian clear cell carcinoma recurrence presenting as subcutaneous nodules[J]. European Journal of Gynaecological Oncology, 2016, 37(4): 575-577.
[13] D. Shintani, H. Yoshida, Y. Imai, K. Fujiwara. Acute pancreatitis induced by paclitaxel and carboplatin therapy in an ovarian cancer patient[J]. European Journal of Gynaecological Oncology, 2016, 37(2): 286-287.
[14] M.J. Kanis, V. Kolev, J. Getrajdman, K. Zakashansky, C. Cohen, J. Rahaman. Carcinosarcoma of the ovary: a single institution experience and review of the literature[J]. European Journal of Gynaecological Oncology, 2016, 37(1): 75-79.
No Suggested Reading articles found!